Trials / Unknown
UnknownNCT06250569
Adenomyosis in Fertile Women in MUSA Criteria
Application of the Revised Morphological Uterus Sonographic Assessment (MUSA) Criteria to Diagnose Adenomyosis in Fertile Women
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 144 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
1. To estimate the prevalence of adenomyosis in fertile women aged 18-30 years using the revised MUSA ultrasound criteria. 2. To evaluate clinical risk factors that are associated with adenomyosis diagnosis in this population
Detailed description
Adenomyosis is a benign condition characterized by the presence endometrial glands and stroma within the myometrium. Its prevalence varies from 5-70%. The definitive diagnosis of adenomyosis is based mainly on histological assessment of hysterectomy specimens. This led to a concept that adenomyosis affects only parous women between 35-50 years who complain of dysmenorrhea and heavy menstrual bleeding. Magnetic Resonance Imaging (MRI) can detect adenomyosis with a sensitivity of 80%. Transvaginal ultrasound using the revised Morphological Uterus Sonographic Assessment (MUSA) criteria can detect adenomyosis non-invasively at a lower cost. Such advancements in imaging techniques allow studying the prevalence of the disease in wider range of population including young women.
Conditions
Timeline
- Start date
- 2024-02-01
- Primary completion
- 2025-06-01
- Completion
- 2025-07-01
- First posted
- 2024-02-09
- Last updated
- 2024-02-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06250569. Inclusion in this directory is not an endorsement.